Bluebird bio
Integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing. Learn more
Launch date
Employees
Market cap
€97.6m
Enterprise valuation
€212m (Public information from Sep 2024)
Share price
$0.56 BLUE.MX
Cambridge Massachusetts (HQ)
Authorizing premium user...